International law firm Integrites successfully represented Farmak company, the leader of Ukrainian pharmaceutical industry, in long-lasting proceedings against Nizhpharm, a part of STADA Arzneimittel AG international group.
The dispute occurred when Russian pharmaceutical company Nizhpharm required to stop the production and sale of the medication, to invalidate the certificate of registration of its name «Chondrasil», owned by Farmak company, and not to use this name in advertising in the future.
Lawyers of ILF Integrites succeeded to protect the interests of Farmak in the Higher Commercial Court of Ukraine. As a result of two-year litigation with company Nizhpharm the Higher Commercial Court of Ukraine rejected the claim of the Nizhpharm company in full.
Integrites team was lead by Ruslan Bernatsky, Senior Partner, and included Anna Tyshchenko, the Counsel of Litigation Practice.
Farmak was established on the basis of M.V. Lomonosov Kyiv Chemical and Pharmaceutical Factory opened in 1925. In 2011 the company clinched the leadership among all pharmaceutical companies supplying medications to the public and operating on Ukrainian market. Farmak has almost 5% share of Ukraine’s pharmaceutical market. Approximately 20% of manufacturing output is exported to CIS, Baltic, and European states.